\
&
Contact us
\
&
Contact us
About the programme
Specific Objective 4 – Advanced Digital Skills supports achieving the target of 20 million ICT specialists employed in Europe by 2030 set in the Digital Decade Policy Programme, while attracting more young people to ICT careers and decreasing the gender gap in the field.
Activities will focus on the industrial needs in digital areas and on the scale up of relevant digital education and training offers in close coordination with industry.
In the 2025-2027 period, activities under SO 4 will comprise the following aspects:
marie.timmermann@fwo.be
+32 2 550 15 59
Find the contact info on the site of WEWIS
The National Contact Points (NCPs) provide support, guidance, and practical information to potential applicants, helping them navigate funding opportunities and application processes.
The Programme Committee (PC) members represent their country in decision-making about the work programmes, evaluate implementation, and provide strategic input on priorities and calls.
Culture and society Advanced Digital Skills
The European Commission has published a call for tenders for EU Code Week activities covering 2027 to 2030. The contract is designed to support coding education, learning resources, outreach, community building and IT system development across Europe. The new contract aims to strengthen the EU Code Week community, attract more young people,... read more
Infosheets contain edited content on aspects related to this programme. They are reviewed at least yearly.
Related links are easy pointers towards external information. We curate the list, but are not liable for the destinations.
Documents contain additional information related to this programme, and are similar to related links.
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
